Overview (18 Sep 2026)
Aspira Pathlab & Diagnostics Ltd
ASPIRA
INE500C01017

Healthcare Service Provider
5.47

Prev. Close
Previous Close
109.53
Current Close
115
Current High
115
Current Low
115
52 Week High
135.88
52 Week Low
49
Resistance 1
115.00
Resistance 2
115.00
Support 1
115.00
Support 2
115.00
Std Deviation
6.25%
DMA 200
82.63
DMA 50
99.68
DMA 20
95.46
Fundamentals and Ratios
Standalone
Trailing EPS
0.05
Forwad EPS
-2.97
Trailing P/E
2300
Forward P/E
NA
PEG Ratio
-26.18
Mkt. Cap (Cr)
Market Cap (Cr)
118.37
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A
Consolidated
Trailing EPS
1.97
Forwad EPS
1.83
Trailing P/E
58.38
Forward P/E
62.96
PEG Ratio
3.22
Mkt. Cap (Cr)
Market Cap (Cr)
118.37
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
Book Value
39.07
P/BV Ratio
4.46
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue6.176.525.128.095.2524.98
Other Income0.120.140.130.140.110.52
Total Income6.296.665.258.235.3625.50
Interest0.090.100.100.100.090.39
Expenditure-6.33-7.35-6.81-6.40-4.80-25.45
PBDT0.000.000.000.000.000.00
Depreciation-0.41-0.40-0.38-0.40-0.37-1.54
PBT-0.04-0.69-1.561.840.470.05
Tax0.000.000.000.000.000.00
Equity0.000.000.000.000.000.00
OPM-0.62-10.56-30.4922.678.940.00
Net Profit-0.04-0.69-1.561.840.470.05
NPM-0.62-10.56-30.4922.678.940
EPS-0.04-0.67-1.521.7800.05
Consolidated
TypeJun-25Mar-25Dec-24Sep-24Jun-24FY24-25
Revenue5.255.785.416.184.6422
Other Income0.110.130.090.080.090.39
Total Income5.365.915.506.254.7322.39
Interest0.090.090.090.080.080.35
Expenditure-4.80-5.10-5.12-5.26-4.75-20.30
PBDT0.000.000.000.000.000.00
Depreciation-0.37-0.37-0.39-0.36-0.38-1.49
PBT0.470.680.310.99-0.022.02
Tax0.000.000.000.000.000.00
Equity0.000.000.000.000.000.00
OPM8.7611.535.5715.83-0.369.04
Net Profit0.420.680.310.990.052.02
NPM7.8811.535.5715.830.999.04
EPS0.410.660.30.960.11.97
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings